Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mylan NV Ord Shs (MYL)

Mylan NV Ord Shs (MYL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
J&J's Prostate Cancer Drug Gets FDA Nod for Expanded Use

J&J's (JNJ) sNDA seeking approval of Erleada for metastatic castration-sensitive prostate cancer is based on data from TITAN study.

MYL : 21.00 (unch)
RDY : 39.11 (+2.89%)
JNJ : 131.65 (+1.18%)
TEVA : 7.45 (-1.06%)
SmarTrend Watching for Potential Rebound in Shares of Mylan Nv After 1.47% Loss

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $21.09 to a high of $21.54. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $21.57 on...

MYL : 21.00 (unch)
Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer

Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic version of AstraZeneca's Faslodex® Injection. Mylan...

MYL : 21.00 (unch)
Mylan Nv Set to Possibly Pullback After Yesterday's Rally of 2.79%

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $19.77 to a high of $22.49. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $21.88...

MYL : 21.00 (unch)
Pfizer is a Top Drugmaker: Is it the Right Time to Buy It?

Pfizer (PFE) sales in the second half may take a hit due to business development activity, incremental currency headwinds and potentially lower sales of key drugs Prevnar and Xeljanz.

MYL : 21.00 (unch)
NVS : 87.07 (+0.83%)
PFE : 36.69 (+0.49%)
GSK : 41.63 (+0.75%)
Mylan Nv (MYL) Crosses Pivot Point Support at $20.13

Shares of Mylan Nv (NASDAQ:MYL) have bearishly opened below the pivot of $20.22 today and have reached the first support level of $20.13. Investors may be interested in a cross of the next downside pivot...

MYL : 21.00 (unch)
Mapi Pharma to Present Series of Recent Advancements for Treating Multiple Sclerosis (MS) at ECTRIMS 2019

Results for Glatiramer Acetate (GA) Depot 3 year analysis in RRMS, GA Depot safety results in RRMS and PPMS, and novel anti-BMP for remyelination will be presented

MYL : 21.00 (unch)
MAPI : N/A (unch)
Acorda (ACOR) Down More Than 60% in 3 Months: Here's Why

Acorda's (ACOR) lead MS drug Ampyra is hit by generic rivalry in the United States, which is hurting the company's top line. Parkinson's disease drug Inbrija can be an ideal replacement.

MYL : 21.00 (unch)
ACOR : 3.49 (+2.95%)
NCNA : 8.00 (+3.90%)
EMMA : 2.1900 (-20.65%)
Forget Pfizer, Add These Big Drugmakers to Your Portfolio

Buy these three large drug companies instead of Pfizer (PFE) as the stock is down this year.

MYL : 21.00 (unch)
AZN : 45.18 (+1.28%)
MRK : 85.16 (+1.42%)
NVS : 87.07 (+0.83%)
RHHBY : 35.7100 (+0.20%)
PFE : 36.69 (+0.49%)
GSK : 41.63 (+0.75%)
Look for Shares of Mylan Nv to Potentially Pullback after Yesterday's 2.52% Rise

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $18.52 to a high of $19.25. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $19.10...

MYL : 21.00 (unch)
Mylan (MYL) Down 12.9% Since Last Earnings Report: Can It Rebound?

Mylan (MYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MYL : 21.00 (unch)
Teva Launches Generic Version of Mylan's EpiPen for KIds

Teva (TEVA) launches generic version of Mylan's (MYL) popular EpiPen Jr allergy treatment at a price of $300 for a pack of two.

MYL : 21.00 (unch)
NVS : 87.07 (+0.83%)
TEVA : 7.45 (-1.06%)
PFE : 36.69 (+0.49%)
SmarTrend Watching for Potential Pullback in Shares of Mylan Nv After 1.56% Gain

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $18.86 to a high of $19.75. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $19.38...

MYL : 21.00 (unch)
Mylan Nv Set to Possibly Pullback After Yesterday's Rally of 1.56%

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $18.86 to a high of $19.75. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $19.38...

MYL : 21.00 (unch)
Omeros Corp has the Best Relative Performance in the Pharmaceuticals Industry (OMER , MYL , LCI , DERM , RVNC )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

MYL : 21.00 (unch)
LCI : 13.80 (+2.91%)
OMER : 18.22 (+0.22%)
Company News For Aug 15, 2019

Companies In The News Are: W,M,CAE,MYL

MYL : 21.00 (unch)
CAE : 25.14 (-1.72%)
W : 122.75 (-4.60%)
M : 15.41 (-1.97%)
Mylan Nv Falls 8.06% on Heavy Volume: Watch For Potential Rebound

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $18.06 to a high of $19.32. Yesterday, the shares fell 8.1%, which took the trading range below the 3-day low of $18.83 on...

MYL : 21.00 (unch)
Watch for Mylan Nv to Potentially Rebound After Falling 8.06% Yesterday

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $18.06 to a high of $19.32. Yesterday, the shares fell 8.1%, which took the trading range below the 3-day low of $18.83 on...

MYL : 21.00 (unch)
Should Value Investors Pick Mylan N.V. (MYL) Stock?

Is Mylan N.V. (MYL) a great pick from the value investor's perspective right now? Read on to know more.

MYL : 21.00 (unch)
Amgen Wins Enbrel U.S. Patent Litigation Against Novartis

Despite lower demand hurting volumes of Enbrel, it remains the largest drug for Amgen (AMGN). A district court decision prevents Novartis from launching Erelzi, its biosimilar version of Enbrel.

MYL : 21.00 (unch)
NVS : 87.07 (+0.83%)
AMGN : 196.94 (+0.66%)
PFE : 36.69 (+0.49%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
AIZ +0.41 , WELL -0.50 , SBAC +5.56 , CCI -0.66 , SO +0.05
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar